title: Using Salmonella enterica serotype typhimurium to model intestinal fibrosis.
authors.forename: Beth A
authors.initials: BA
authors.lastname: McCormick
mesh_terms: D000818:Animals; D002432:Cecum / Q000378:metabolism / Q000382:microbiology / Q000473:pathology*; D002908:Chronic Disease; D024042:Collagen Type I / Q000378:metabolism; D003106:Colon / Q000378:metabolism / Q000382:microbiology / Q000473:pathology*; D055513:Connective Tissue Growth Factor; D003424:Crohn Disease / Q000150:complications* / Q000378:metabolism / Q000473:pathology; D016207:Cytokines / Q000378:metabolism; D004195:Disease Models, Animal; D004760:Enterocolitis / Q000150:complications* / Q000235:genetics / Q000378:metabolism / Q000382:microbiology / Q000473:pathology; D005347:Fibroblasts / Q000473:pathology; D005355:Fibrosis; D017874:Immediate-Early Proteins / Q000378:metabolism; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism; D007410:Intestinal Diseases / Q000209:etiology / Q000235:genetics / Q000378:metabolism / Q000382:microbiology / Q000473:pathology*; D051379:Mice; D009154:Mutation; D012480:Salmonella Infections / Q000150:complications* / Q000235:genetics / Q000378:metabolism / Q000382:microbiology / Q000473:pathology; D012486:Salmonella typhimurium / Q000235:genetics / Q000378:metabolism / Q000472:pathogenicity; D012720:Severity of Illness Index; D013045:Species Specificity; D013307:Streptomycin / Q000008:administration & dosage; D013997:Time Factors; D053773:Transforming Growth Factor beta1 / Q000378:metabolism; D015854:Up-Regulation; D037521:Virulence Factors / Q000378:metabolism
chemical_list: C526318:CCN2 protein, mouse; D024042:Collagen Type I; D016207:Cytokines; D017874:Immediate-Early Proteins; D036341:Intercellular Signaling Peptides and Proteins; D053773:Transforming Growth Factor beta1; D037521:Virulence Factors; D055513:Connective Tissue Growth Factor; D007334:Insulin-Like Growth Factor I; D013307:Streptomycin